Single‐dose, preoperative MMC‐EMDA vs single‐dose, postoperative MMC‐PD
Serious adverse events
It is very uncertain whether single‐dose, preoperative MMC‐EMDA changes serious adverse events compared with single‐dose, postoperative MMC‐PD (very low certainty).
1 finding from 1 review
- Intravesical electromotive drug administration for non‐muscle invasive bladder cancer 2017 · Cochrane Headline outcomes onlyRR 0.79 [0.3, 2.05]1 study · 236 participantsVery low